CommercialCoverageMedium impact
Responsive Neurostimulation for the Treatment of Refractory Focal Epilepsy 7.01.103
Excellus BlueCross BlueShield·Neurology, Neurosurgery·Nervous Systems (Neurology)
Effective date
May 21, 2026
We identified it
Jun 20, 2026
Summary
New coverage policy for Responsive Neurostimulation (RNS) devices for treating refractory focal epilepsy, establishing specific medical necessity criteria including age requirements, seizure frequency, and contraindications. Policy also covers device replacement criteria and excludes coverage for cosmetic upgrades or negligence-related damage.
Action Required
Before May 21, 2026: Billing team must review current RNS device claims and ensure all future claims meet the new medical necessity criteria including patient age 18+, 3+ disabling seizures per month, failure of 2+ antiepileptic medications, and proper documentation of contraindications. Update prior authorization processes to verify these requirements. Claims not meeting criteria will be denied.